Associations between small size at birth and abnormal cardiovascular parameters in later life have been reported. It is, however, unknown whether the effect of a small size at birth on cardiovascular risk factors in later life is due to a small size for gestational age or due to prematurity. Due to advances in neonatal care, survival of preterm infants has significantly improved, and nowadays an increasing number of these children reach adulthood. It is, therefore, of increasing importance to assess the long-term effect of prematurity on determinants for cardiovascular disease.
D
yslipidemia is one of the major determinants for cardiovascular disease (CVD) and is characterized by raised levels of total cholesterol (TC), low-density lipoprotein (LDLc), triglyceride (Tg), apolipoprotein B (ApoB), and lipoprotein a [Lp(a)], together with reduced levels of high-density lipoprotein (HDLc) and apolipoprotein A-I (ApoA-I) (1) (2) (3) (4) . Several studies reported an association between a small size at birth and fat mass and/or components of the lipid profile in later life (5) (6) (7) (8) (9) (10) (11) (12) , which might indicate that subjects born with a low birth weight would have an increased risk for developing CVD. These reports have contributed to the hypothesis that impaired fetal growth may be associated with abnormal metabolic and cardiovascular parameters in later life.
Small size at birth may be due to preterm birth, poor fetal growth, or a combination of both. Most studies fo-cused on subjects with a low birth weight and did not have information on gestational age, did not correct for it, or only included subjects born term (6 -9) . It is, therefore, difficult to determine whether the effect of a small size at birth on cardiovascular risk factors in later life is due to a small size for gestational age (SGA) or to prematurity. Previous research by Leunissen et al. (10) showed that low birth weight was no significant determinant of serum lipid levels in young adults born term. We therefore hypothesized that the previously described effect of a small birth size on serum lipid levels might be due to preterm birth rather than being born SGA.
Approximately 7% of all Dutch newborns are born preterm (gestational age Ͻ37 wk, Central Bureau of Statistics 2007, The Netherlands). Preterm infants are frequently exposed to early postnatal growth restriction, glucocorticoid treatment, and stressful events. This may be important in the development of later organ dysfunction and adverse vascular outcome and could increase the effect of prematurity on fat mass and lipid levels in later life. To date, most long-term follow-up studies have focused on neurodevelopmental and respiratory complications of preterm infants (13) (14) (15) (16) , with little attention to cardiovascular outcome. Due to advances in neonatal care, survival of preterm and very low birth weight infants has significantly improved, and an increasing number of these Significant P values are indicated in boldface.
children reach adulthood. It is, therefore, of increasing importance to assess the long-term effect of prematurity on determinants for CVD.
In line with our hypothesis that preterm birth is associated with an adverse lipid profile in early adulthood, we also hypothesized that being born preterm is associated with more fat mass because most lipid levels are influenced by the amount of fat mass. Therefore, we investigated the long-term effects of gestational age and particularly preterm birth on these outcome parameters. We also assessed whether being born SGA, in addition to preterm birth, increases the risk for adverse cardiovascular parameters in this group.
Subjects and Methods

Subjects
The PREMS/PROGRAM study cohort consists of 492 healthy subjects, aged 18 to 24 yr. Preterm-born subjects (gestational age Ͻ36 wk, PREMS study) had been admitted to the neonatal intensive care unit of the Erasmus University Medical Centre shortly after birth. Term subjects (gestational age Ն36 wk, PROGRAM study) were randomly selected from hospitals in The Netherlands, where they had been registered because of being born SGA [defined as birth length below Ϫ2 SD score (SDS)]. In addition, healthy term subjects of different schools were randomly asked to participate (PROGRAM study).
The participation rate of the PREMS/PROGRAM study cohort was 79.5%. All participants fulfilled the same inclusion criteria: 1) age 18 -24 yr; 2) Caucasian; 3) born singleton; 4) uncomplicated neonatal period without signs of severe asphyxia (defined as an Apgar score Ͻ3 after 5 min), without sepsis or long-term complications of respiratory ventilation, such as bronchopulmonary dysplasia; and 5) maximum duration of respiratory ventilation and/or oxygen supply of 2 wk during the neonatal period. Subjects with a serious neonatal complication (e.g. necrotizing enterocolitis, respiratory problems requiring glucocorticoids, degree 3 or more intraventricular hemorrhage, spastic hemiplegia or quadriplegia), an endocrine or metabolic disorder, chromosomal defects, syndromes or serious dysmorphic symptoms suggestive for a yet unknown syndrome were excluded. Subjects with a condition known to interfere with growth, including GH deficiency, severe chronic illness, emotional deprivation, GH treatment, glucocorticosteroids treatment, and radiotherapy, were also excluded.
Data regarding gestational age and birth size were taken from hospital records and records from community health services and general practitioners. Information regarding socioeconomic status (SES), cigarette smoking, alcohol consumption, and usage of oral contraceptives was obtained using questionnaires. SES was determined by using educational level of the participant, which was assessed by the highest grade of school completed or currently participating in, and categorized into: 1) high (higher general secondary education or higher); 2) median (junior general secondary education-secondary vocational education); and 3) low education (preparatory middle-level vocational education or lower).
Of the 492 participants who entered the study, 37 had incomplete data on body composition and lipid levels, resulting in a total number of 455 eligible subjects for analyses. There were no differences in anthropometric measurements between the included and excluded participants.
Based on SDS of birth length and adult height, the subjects were also assigned to one of three subgroups. To increase the statistical power for subgroup comparison, the cutoff values for small birth size and short adult height were set at Ϫ2 SDS, and the cutoff values for normal birth size and normal adult height were set at Ϫ1 SDS. This resulted in a total of 269 participants who were included in one of the three subgroups:
• Subjects born SGA (birth length below Ϫ2 SDS) with a short adult height (below Ϫ2 SDS) (SGA-S; n ϭ 49).
• Subjects born SGA (birth length below Ϫ2 SDS) with catch-up growth resulting in a normal adult height (above Ϫ1 SDS) (SGA-CU; n ϭ 85). Data are adjusted for the interaction term birth length SDS‫ء‬adult height SDS.
Significant P values are indicated in boldface.
• Subjects born appropriate for gestational age (AGA; birth length above Ϫ1 SDS) with a normal adult height (above Ϫ1 SDS) (n ϭ 135).
All participants were invited to visit the Erasmus University Medical Centre in Rotterdam, The Netherlands. They had been fasting for at least 12 h and had abstained from smoking and alcohol for at least 16 h. The center's Medical Research Ethics Committee approved this study. Written informed consent was obtained from all the participants.
Anthropometry
Adult height was measured to the nearest 0.1 cm using a Harpenden stadiometer (Holtain, Ltd., Crymych, UK). Weight was measured to the nearest 0.1 kg on a digital scale (Servo Balance KA-20-150S; Servo Berkel Prior, Katwijk, The Netherlands). All anthropometric measurements were performed twice, and the mean value was used for analysis. Body mass index (BMI) was calculated by dividing weight in kilograms by the square of height in meters and rounded to the nearest tenth.
Body composition
Body composition was measured by dual-energy x-ray absorptiometry (DXA, type Lunar-Prodigy; GE Healthcare, Chalfont St. Giles, UK). All scans were made on the same machine, and quality assurance was performed daily. For this type of DXA, the intraassay coefficient of variation has been reported to be 0.41-0.88% for fat tissue and 1.57-4.49% for lean body mass (LBM) (17) .
Laboratory methods
After centrifugation, all samples were kept frozen until assayed (Ϫ80 C). Fasting levels of TC, Tg, ApoB, Lp(a), HDLc, and ApoA-I were measured. LDLc was calculated using the Friedewald formula: LDLc (mmol/liter) ϭ TC Ϫ HDLc Ϫ 0.45‫ء‬Tg (18) .
TC and Tg were measured using an automated enzymatic method with the CHOD-PAP reagent kit and with the GPO-PAP reagent kit, respectively (Roche Diagnostics, Mannheim, Germany). HDLc was measured using a homogeneous enzymatic colorimetric assay (Roche Diagnostics); ApoA-I, ApoB, and Lp(a) were determined by rate nephelometry on the Image Immunochemistry System, according to the manufacturer's instructions (Beckman Coulter, Mijdrecht, The Netherlands). The intraassay variations of measurements of TC, Tg, and HDLc were 2.9, 3.3, and 3.9%, respectively. Between-run coefficients of variation for ApoA-I, ApoB, and Lp(a) were 4.2, 2.8, and 6.9% at levels of 0.94, 0.53, and 0.35 g/liter, respectively .
Statistics
To correct for gestational age, SDS for birth length and birth weight were calculated (19) . To adjust for gender and age, SDS for adult height and adult weight were calculated (20) . ANOVA was used to determine whether there were differences between subjects born either preterm or term with regard to clinical characteristics. Differences in smoking, alcohol use, SES, and oral contraceptive use were determined using a 2 test. Multiple linear regression analysis was used to determine differences between preterm and term subjects regarding fat mass (adjusted for age, gender, SES, birth length SDS, birth weight SDS, and adult height SDS) and regarding lipid levels (adjusted for age, gender, SES, alcohol, smoking, birth length SDS, adult height SDS, fat mass, and LBM). All lipid levels were log-transformed before analyses because of a skewed distribution. We also compared the SGA-S subjects born preterm and term, the SGA-CU subjects born preterm and term, and the AGA subjects born preterm and term.
The prevalences of raised TC levels (TC Ͼ6.5 mmol/liter), raised LDLc levels (LDLc Ͼ4.12 mmol/liter), raised Tg levels (Tg Ͼ2.0 mmol/liter), raised ApoB levels (ApoB Ն1.20 g/liter), raised Lp(a) levels [Lp(a) Ͼ0.30 g/liter], reduced HDLc levels (HDLc Ͻ0.9 mmol/liter, males; or Ͻ1.1 mmol/liter, females), and reduced ApoA-I levels (ApoA-I Յ1.20 g/liter) were calculated for the preterm and term subjects. Differences in these prevalences were analyzed using a 2 test. Multiple linear regression analysis was performed to determine the association between gestational age and fat mass (total fat mass, trunk fat mass, and limb fat mass). In model A, we entered gestational age, age, gender, birth length SDS, birth weight SDS, and adult height SDS. Next, we added SES, smoking, and alcohol use to model A (model B). Finally, adult weight SDS was added to the model, resulting in model C. By adding adult weight SDS into the model, we investigated the association be- tween gestational age and fat mass, whereas adult weight SDS was assumed constant, thus indirectly demonstrating the association between gestational age and fat percentage. Oral contraceptive use was subsequently added and analyzed as a possible confounder only in the female subjects.
To study the effect of gestational age on TC, LDLc, Tg, ApoB, Lp(a), HDLc, and ApoA-I, we first entered gestational age, age, gender, birth length SDS, birth weight SDS, and adult height SDS (model A). Next, we added SES, smoking, alcohol use and adult weight SDS (model B). Finally, adult weight SDS was replaced by LBM and fat mass to investigate the relative effect of muscle and/or fat mass (model C). Oral contraceptive use was then added and analyzed as a possible confounder in the female subjects.
The interaction term birth length SDS‫ء‬adult height SDS was added to all multiple linear regression models because the study group had been selected on birth length and adult height to ensure that the effect of these variables was modeled correctly.
To evaluate whether being born SGA had an effect on adult cardiovascular parameters in addition to being born preterm, preterm (yes or no) and SGA (yes or no) were added to a multiple linear regression model, with adjustments for possible confounders (age, gender, and SES in the analysis with fat mass as dependent variable; age, gender, SES, alcohol, smoking, fat mass, and LBM in the analyses with lipid levels as dependent variables). Within the SGA subgroups, the effect of showing spontaneous catch-up growth to an adult height greater than Ϫ1 SDS (yes or no) was assessed by then adding catch-up growth as an independent parameter into this multiple linear regression analysis.
Statistical package SPSS version 16.0 (SPSS, Inc., Chicago, IL) was used for analyses. Results were regarded statistically significant if the P value was Ͻ0.05.
Results
Clinical characteristics
The total study population consisted of 455 subjects. The clinical characteristics of the total study population, subdivided into adults born preterm vs. term, are shown in Table 1 . Young adults born preterm had a higher birth weight SDS (P Ͻ 0.001), adult height SDS (P Ͻ 0.001), and adult weight SDS (P ϭ 0.002) than subjects born term. Mean BMI SDS was well within the normal range in both preterm and term subjects. The percentage of alcohol users and smokers was similar for preterm and term subjects, as was the SES. Females born preterm used oral contraceptives less frequently than those born term (P ϭ 0.036).
Preterm vs. term
Comparison of preterm and term subjects in the total study group showed that, after adjustment for possible confounders, preterm subjects had significantly more total fat mass (P ϭ 0.017), trunk fat mass (P ϭ 0.021), and limb fat mass (P ϭ 0.017) than subjects born term. However, preterm subjects had significantly lower Lp(a) levels (P Ͻ 0.001) and higher ApoA-I levels (P Ͻ 0.001) than term subjects. TC levels were significantly lower in preterm compared with term subjects (P ϭ 0.030) ( Table 1) . Table 2 shows the prevalence of lipid levels above or below the normal range in the preterm and term subjects. There was a significant difference in prevalence of reduced ApoA-I levels between the preterm (12.6%) and term (33.3%) subjects. Abnormal TC, LDLc, Tg, ApoB, Lp(a), and HDLc levels occurred less frequently in preterm than in term subjects. However, these differences did not reach significance.
Gestational age
Using multiple linear regression analyses, we studied the effect of gestational age, as a continuous variable, on Data are adjusted for the interaction term birth length SDS‫ء‬adult height SDS.
Significant P values are indicated in boldface. a Levels are log-transformed for analyses.
fat mass and lipid levels after adjustment for several confounders.
Relationship between gestational age and fat mass Gestational age was inversely associated with total fat mass (P ϭ 0.015), trunk fat mass (P ϭ 0.010), and limb fat mass (P ϭ 0.029), after adjustment for age, gender, birth length SDS, birth weight SDS, and adult height SDS (Table  3) . These associations remained significant after additional correction for SES, smoking, and alcohol use. Adjustment for oral contraceptive use in the female subjects did not change these results. Within the female subjects, oral contraceptive use did not significantly influence the variance in fat mass (total, trunk, and limb fat mass, data not shown).
By adding adult weight SDS to the analyses, we indirectly demonstrate the association between gestational age and fat percentage (see Subjects and Methods). Lower gestational age remained associated with a higher percentage of total fat mass (P ϭ 0.003), trunk fat mass (P ϭ 0.003), and limb fat mass (P ϭ 0.006).
Relationship between gestational age and lipid levels
Gestational age was not significantly associated with TC (P ϭ 0.241), LDLc (P ϭ 0.211), Tg (P ϭ 0.227), ApoB (P ϭ 0.099), and HDLc (P ϭ 0.953), also after adjustment for age, gender, birth length SDS, birth weight SDS, adult height SDS, SES, smoking, alcohol use, LBM, and fat mass (Tables 4-6 ). Adding oral contraceptive use to the model did not change these results. Oral contraceptive use was, however, a significant determinant of the variance in Tg (P Ͻ 0.001), ApoA-I (P ϭ 0.026), and ApoB (P ϭ 0.007).
Gestational age was positively associated with Lp(a) (P ϭ 0.002) and inversely associated with ApoA-I (P Ͻ 0.001), also after adjustment for possible confounders (model C), indicating that subjects with a lower gestational age had lower levels of Lp(a) and higher levels of ApoA-I.
Preterm birth and SGA
Being born SGA, in addition to preterm birth, had no effect on total fat mass (P ϭ 0.894), trunk fat mass (P ϭ 0.841), and limb fat mass (P ϭ 0.957). Catch-up growth to a normal height after SGA birth was also not an additional contributor to the variance in total fat mass (P ϭ 0.145), trunk fat mass (0.153), and limb fat mass (P ϭ 0.147).
Furthermore, being born SGA did not additionally affect the variance in TC (P ϭ 0.142), LDLc (P ϭ 0.086), Tg (P ϭ 0.370), Lp(a) (P ϭ 0.397), HDLc (P ϭ 0.201), or ApoA-I (P ϭ 0.536). SGA birth did have a small positive effect on ApoB (P ϭ 0.034). Within the subjects who were born SGA, catch-up growth was not an additional contributor to the variance in Tg (P ϭ 0.904), Lp(a) (P ϭ 0.752), HDLc (P ϭ 0.457), and ApoA-I (P ϭ 0.993). Catch-up growth did contribute to the variance in TC (P ϭ 0.033), LDLc (P ϭ 0.009), and ApoB (P ϭ 0.009), in addition to being born preterm and SGA.
Discussion
Our study in 455 young adults shows that lower gestational age is associated with a higher percentage of total fat mass, trunk fat mass, and limb fat mass in early adulthood. In addition, our subgroup analysis shows that young adults born preterm have more fat mass. A shorter gestational age was, however, also associated with lower serum Lp(a) and higher ApoA-I levels. Thus, in accordance with our hypothesis, subjects born preterm are prone to develop a less favorable body composition later in life, but in contrast to our expectations they have a relatively favorable lipid profile. Being born SGA, in addition to being born preterm, had no effect on fat mass and most lipid levels, except for a small effect on ApoB levels. Body fat mass and, in particular, trunk fat mass are major risk factors for cardiovascular disease (21) . At the age of 18 -24 yr, adults born preterm had significantly more fat mass (total fat mass, trunk fat mass, and limb fat mass) than adults born term, although BMI SDS was within the normal range and was similar in both groups. Some studies showed that children born preterm were shorter and lighter during childhood than children born term (22, 23) . We could not confirm such results in our population of young adults. Our results are in line with previous research in a cohort of healthy young adults. At the age of 18 -27 yr, subjects born preterm had significantly more total fat mass and trunk fat mass than subjects born term, measured by whole body magnetic resonance imaging (12) . Doyle et al. (24) also described a relative increase in BMI in subjects born preterm before the subjects reached the age of 20 yr. It might well be that, under the influence of hormonal changes in puberty and adolescence, preterm subjects undergo a relatively large increase in fat mass. Further longitudinal follow-up studies in childhood and adolescence are important to confirm these findings.
Another study found no differences in total fat mass between preterm and term subjects in 87 young adults (5) . This might be due to the fact that fat mass was estimated using bioelectrical impedance analysis, which is known to underestimate total body fat percentage and fat tissue compared with DXA (25) . Another reason for the difference might be that our cohort comprised a larger group of preterm subjects, which enables us to find differences with more statistical power.
The multiple linear regression analysis showed that the amount of fat mass was a significant contributor to the variance in most lipid levels. Because we showed that subjects born preterm had more fat mass, we expected a more adverse lipid profile. Gestational age was, however, not associated with TC, LDLc, Tg, ApoB, and HDLc. In our subgroup analyses, adults born preterm did have lower TC than those born term, but this difference is not likely to be clinically significant because preterm and term subjects had the same prevalence of abnormal TC levels. Our study was performed in young adults, and clinical manifestations of CVD do not usually occur before middle age. Assuming that the amount of fat mass of preterm subjects remains higher throughout adulthood, they might develop a more adverse lipid profile on the longer term.
A shorter gestational age was associated with lower Lp(a) levels and higher ApoA-I levels, and subjects born preterm had a significantly lower prevalence of adverse ApoA-I levels (12.6%), compared with those born term Data are adjusted for the interaction term birth length SDS‫ء‬adult height SDS.
(33.3%). This might indicate that young adults born preterm have a more favorable lipid profile than those born term, although their body composition seems to be disadvantageous. Noteworthy, Lp(a) and ApoA-I levels were the only lipids not influenced by adult weight SDS. This indicates that Lp(a) and ApoA-I levels are not directly influenced by fat or fat accumulation but are determined by other factors, like genetic factors (10, 26, 27) . A relatively high percentage of our study population consisted of subjects born SGA (36.7%), compared with the normal population in which the prevalence of SGA is only 2.3%. This enabled us to study the additional effect of a small size at birth with more statistical power. In practice, preterm infants are more prone to impaired fetal growth than infants born term (28) . We found no additional effect of being born SGA on the variance of fat mass and only a marginal effect of being born SGA on ApoB levels, whereas SGA had no effect on all other lipid levels. This is in accordance with our previous report by Leunissen et al. (10) , who showed in subjects born term that fat mass of young adults born SGA was similar to fat mass of controls born AGA and that fat accumulation during childhood significantly determined serum lipid levels, whereas birth size did not. Irving et al. (11) also showed that among premature babies, those with intrauterine growth restriction were not measurably more disadvantaged regarding cardiovascular risk factors, e.g. lipid levels, than those born with birth weights AGA. This confirms our hypothesis that the previously described effect of small birth size on fat mass and lipid levels is due to preterm birth rather than being born SGA.
Family history is a well-known independent risk factor for future abnormal lipid profiles, as well as for CVD (29) . It would have been of additional value to include this determinant of CVD in our analyses. Unfortunately, we did not have sufficient information to assess family history in our cohort of young adults. However, none of the subjects who fully completed the questionnaires mentioned a family history of hyperlipidemia, CVD, hypertension, or type 2 diabetes mellitus.
In conclusion, in our cohort of 455 young adults, preterm birth was associated with more total fat mass, trunk fat, and limb fat mass but also with a relatively favorable lipid profile. Further research is needed to evaluate whether or not these differences predispose subjects born preterm to CVD later in life. Such data are of major importance as an increasing number of children born preterm reach adulthood. Data are adjusted for the interaction term birth length SDS‫ء‬adult height SDS.
